Professor Kyriakos E. Kypreos

Cited by

	All	Since 2016
Citations	2696	1286
h-index	33	23
i10-index	58	44

280

140

210

1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202113 6 16 19 27 48 53 32 65 74 59 102 172 167 152 187 180 210 216 187 271 198 202

Public access

View all

8 articles

2 articles

available

not available

Based on funding mandates

Co-authors

Eleni KaraviaUniversity of Patras, School of Health Sciences, Department of Medicine, Pharmacology laboratoryVerified email at upatras.gr
Ko Willems van DijkLeiden University Medical CenterVerified email at lumc.nl
Evangelia ZvintzouUniversity of PatrasVerified email at upatras.gr
Dionysios J. Papachristou MD, PhDProfessor, Univ. of Patras, School of Medicine, Patras, Greece; Adj. Professor, Univ. of PittsburghVerified email at med.upatras.gr
Louis HavekesTNO Metabolic Health Research and Prof. Leiden University Medical Center, Leiden, the NetherlandsVerified email at tno.nl
Xepapadaki EvaUniversity of PatrasVerified email at upatras.gr
PERISTERA IOANNA PETROPOULOUPostdoctoral Research Scientist, Helmholtz Zentrum MuenchenVerified email at helmholtz-muenchen.de
Angelika ChroniNational Center for Scientific Research DemokritosVerified email at bio.demokritos.gr
Iordanis KaragiannidisAssociate Professor of Medicine, UCLAVerified email at mednet.ucla.edu
Harry C. BlairProfessor of Pathology, University of PittsburghVerified email at pitt.edu
George SakellaropoulosSchool of Medicine, University of PatrasVerified email at med.upatras.gr
Patrick RensenProfessor of Endocrinology, Leiden University Medical Center, Leiden, The NetherlandsVerified email at lumc.nl
Konstantinos DrosatosLewis Katz School of Medicine at Temple UniversityVerified email at temple.edu
Shlomo SassonProfessor of PhramacologyVerified email at mail.huji.ac.il
Giuseppe MaulucciNeuroscience dept, Biophysics section Università Cattolica del Sacro CuoreVerified email at unicatt.it
Loukianos RallidisNational and Kapodistrian University of AthensVerified email at med.uoa.gr
Bas TeusinkProfessor of Systems Biology, VU University AmsterdamVerified email at vu.nl
Thais CesarSao Paulo State UniversityVerified email at fcfar.unesp.br
CARLA FERRERIConsiglio Nazionale delle RicercheVerified email at isof.cnr.it
CHRYSSOSTOMOS CHATGILIALOGLUConsiglio Nazionale delle RicercheVerified email at isof.cnr.it

Professor Kyriakos E. Kypreos

University of Patras School of Health Sciences, Department of Medicine, Pharmacology laboratory

Verified email at upatras.gr - Homepage

Metabolic syndrome Lipid and lipoprotein metabolism Dyslipidemia Cardiovascular health White adipose tissue (wat) and Brown


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis EM Tsompanidi, MS Brinkmeier, EH Fotiadou, SM Giakoumi, KE Kypreos Atherosclerosis 208 (1), 3-9, 2010	203	2010
Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT KE Kypreos, VI Zannis Biochemical Journal 403 (2), 359-367, 2007	112	2007
Androgen deficiency and atherosclerosis: The lipid link AM Traish, R Abdou, KE Kypreos Vascular pharmacology 51 (5-6), 303-313, 2009	99	2009
Testosterone and cardiovascular disease: an old idea with modern clinical implications AM Traish, KE Kypreos Atherosclerosis 214 (2), 244-248, 2011	91	2011
Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer VI Zannis, A Chroni, KE Kypreos, HY Kan, TB Cesar, EE Zanni, ... Current opinion in lipidology 15 (2), 151-166, 2004	90	2004
Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice I Karagiannides, R Abdou, A Tzortzopoulou, PJ Voshol, KE Kypreos The FEBS journal 275 (19), 4796-4809, 2008	89	2008
Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet IE Triantaphyllidou, E Kalyvioti, E Karavia, I Lilis, KE Kypreos, ... Osteoarthritis and cartilage 21 (2), 322-330, 2013	81	2013
Fatty acid-related modulations of membrane fluidity in cells: detection and implications G Maulucci, O Cohen, B Daniel, A Sansone, PI Petropoulou, S Filou, ... Free radical research 50 (sup1), S40-S50, 2016	79	2016
Lipoproteins and atherogenesis VI Zannis, KE Kypreos, A Chroni, D Kardassis, EE Zanni Molecular mechanisms of atherosclerosis 8, 111-174, 2004	79	2004
Domains of Apolipoprotein E Contributing to Triglyceride and Cholesterol Homeostasis in Vivo: CARBOXYL-TERMINAL REGION 203–299 PROMOTES HEPATIC VERY LOW DENSITY LIPOPROTEIN … KE Kypreos, KW van Dijk, A van der Zee, LM Havekes, VI Zannis Journal of Biological Chemistry 276 (23), 19778-19786, 2001	74	2001
ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia KE Kypreos Biochemistry 47 (39), 10491-10502, 2008	69	2008
Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity KE Kypreos, I Karagiannides, EH Fotiadou, EA Karavia, MS Brinkmeier, ... The FEBS journal 276 (20), 5720-5728, 2009	64	2009
Domains of apoE required for binding to apoE receptor 2 and to phospholipids: implications for the functions of apoE in the brain X Li, K Kypreos, EE Zanni, V Zannis Biochemistry 42 (35), 10406-10417, 2003	63	2003
Increased CUG triplet repeat-binding protein-1 predisposes to impaired adipogenesis with aging I Karagiannides, T Thomou, T Tchkonia, T Pirtskhalava, KE Kypreos, ... Journal of Biological Chemistry 281 (32), 23025-23033, 2006	62	2006
SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux A Chroni, TJF Nieland, KE Kypreos, M Krieger, VI Zannis Biochemistry 44 (39), 13132-13143, 2005	55	2005
Apolipoprotein AI modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice EA Karavia, DJ Papachristou, K Liopeta, IE Triantaphyllidou, ... Molecular Medicine 18 (6), 901-912, 2012	53	2012
Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein AI (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce … A Chroni, HY Kan, KE Kypreos, IN Gorshkova, A Shkodrani, VI Zannis Biochemistry 43 (32), 10442-10457, 2004	52	2004
Effects of bariatric surgery on HDL structure and functionality: results from a prospective trial E Zvintzou, G Skroubis, A Chroni, PI Petropoulou, C Gkolfinopoulou, ... Journal of clinical lipidology 8 (4), 408-417, 2014	50	2014
The hepatic uptake of VLDL in lrp− ldlr−/− vldlr−/− mice is regulated by LPL activity and involves proteoglycans and SR-BI L Hu, CC van der Hoogt, SMSE Santo, R Out, KE Kypreos, ... Journal of lipid research 49 (7), 1553-1561, 2008	50	2008
A-myb is expressed in bovine vascular smooth muscle cells during the late G1-to-S phase transition and cooperates with c-myc to mediate progression to S phase DJ Marhamati, RE Bellas, M Arsura, KE Kypreos, GE Sonenshein Molecular and cellular biology 17 (5), 2448-2457, 1997	49	1997

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow this author

Cited by

Co-authors